Deferral of publication of Financial Statements
Updated : 07:05
London, 27 March 2020
Joint FCA/FRC Statement on Publication of Financial Statements
In light of the joint statement issued on 26 March 2020 by the Financial Conduct Authority ("FCA") and the Financial Reporting Council ("FRC") recommending that public companies should re-consider their timetables for publication of financial information to ensure accurate and carefully prepared disclosures in light of the COVID-19 outbreak, the Board of Georgia Healthcare Group PLC (the "Company") confirms that the Company will defer the publication of its audited Annual Report and Accounts (the "Report").
The Company had intended to publish its Annual Report for the year ending 31 December 2019 on March 27, 2020. The Company now plans to publish the Report in mid-April 2020.
Name of authorised official of issuer responsible for making notification:
Ketevan Kalandarishvili, Head of Investor Relations
About Georgia Healthcare Group PLC
Georgia Healthcare Group PLC is a UK incorporated holding company of the largest healthcare services provider in the fast-growing, predominantly privately-owned, Georgian healthcare services market. GHG's leadership position is underpinned by offering the most comprehensive range of inpatient and outpatient services targeting the mass market segment through its vertically integrated network of 18 hospitals and 34 clinics. GHG is the single largest market participant, accounting for 24% of total hospital bed capacity in the country, as of 31 December 2019. GHG is also the largest pharmaceuticals retailer and wholesaler in Georgia, with approximately 32% market share by revenue and the largest provider of medical insurance in Georgia with a 32% market share based on net insurance premiums earned and approximately c.236,000 insurance customers. GHG employed a total of c.15,900 people as at 31 December 2019, including c.3,600 physicians and 2,900 pharmacists.
For further information, please visit ghg.com.ge or contact:
Nikoloz Gamkrelidze |
| Irakli Gogia | Ketevan Kalandarishvili |
CEO |
| CFO | Head of Investor Relations |
+995 322 550505 (5077) |
| +995 322 550505 (5088) | +995 322 550505 (5079) |
|
This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.